Michael Ryskin
Stock Analyst at B of A Securities
(1.45)
# 3,299
Out of 4,749 analysts
34
Total ratings
50%
Success rate
-2.4%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Maintains: Neutral | $52 → $54 | $57.39 | -5.91% | 3 | Dec 13, 2024 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $219.11 | -5.98% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $46.98 | -14.86% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $6.85 | +38.69% | 1 | Jun 25, 2024 | |
| MRVI Maravai LifeSciences Holdings | Upgrades: Buy | $10 → $8 | $4.93 | +62.27% | 2 | Dec 12, 2023 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $14.23 | +68.66% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $22.28 | +7.72% | 2 | Jul 31, 2023 | |
| ZTS Zoetis | Maintains: Buy | $225 → $180 | $170.90 | +5.32% | 7 | Nov 4, 2022 | |
| OMIC Singular Genomics Systems | Downgrades: Underperform | $90 | $19.82 | +354.09% | 3 | Aug 10, 2022 | |
| IDXX IDEXX Laboratories | Downgrades: Neutral | $550 → $470 | $422.05 | +11.36% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.24 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $80 → $52 | $25.08 | +107.38% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $3.71 | +169.54% | 2 | Nov 10, 2021 |
Tempus AI
Dec 13, 2024
Maintains: Neutral
Price Target: $52 → $54
Current: $57.39
Upside: -5.91%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $219.11
Upside: -5.98%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $46.98
Upside: -14.86%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $6.85
Upside: +38.69%
Maravai LifeSciences Holdings
Dec 12, 2023
Upgrades: Buy
Price Target: $10 → $8
Current: $4.93
Upside: +62.27%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $14.23
Upside: +68.66%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $22.28
Upside: +7.72%
Zoetis
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $170.90
Upside: +5.32%
Singular Genomics Systems
Aug 10, 2022
Downgrades: Underperform
Price Target: $90
Current: $19.82
Upside: +354.09%
IDEXX Laboratories
May 5, 2022
Downgrades: Neutral
Price Target: $550 → $470
Current: $422.05
Upside: +11.36%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $7.24
Upside: -
Nov 11, 2021
Downgrades: Neutral
Price Target: $80 → $52
Current: $25.08
Upside: +107.38%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $3.71
Upside: +169.54%